FMC Corp has a consensus price target of $83.57 based on the ratings of 24 analysts. The high is $155 issued by Redburn Partners on March 17, 2023. The low is $50 issued by JP Morgan on May 13, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Barclays, and JP Morgan on July 16, 2024, June 26, 2024, and May 13, 2024, respectively. With an average price target of $58 between Wells Fargo, Barclays, and JP Morgan, there's an implied 0.31% upside for FMC Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 7.23% | Wells Fargo | Richard Garchitorena | $68 → $62 | Maintains | Equal-Weight | Get Alert |
06/26/2024 | Buy Now | 7.23% | Barclays | Benjamin Theurer | → $62 | Initiates | → Equal-Weight | Get Alert |
05/13/2024 | Buy Now | -13.52% | JP Morgan | Jeffrey Zekauskas | $53 → $50 | Maintains | Neutral | Get Alert |
05/10/2024 | Buy Now | 40.09% | RBC Capital | Arun Viswanathan | $65 → $81 | Maintains | Outperform | Get Alert |
05/08/2024 | Buy Now | 40.09% | Keybanc | Aleksey Yefremov | $79 → $81 | Maintains | Overweight | Get Alert |
05/08/2024 | Buy Now | 17.61% | Wells Fargo | Richard Garchitorena | $65 → $68 | Maintains | Equal-Weight | Get Alert |
05/07/2024 | Buy Now | -1.42% | Mizuho | Christopher Parkinson | $55 → $57 | Maintains | Neutral | Get Alert |
04/09/2024 | Buy Now | 36.63% | Keybanc | Aleksey Yefremov | $76 → $79 | Maintains | Overweight | Get Alert |
03/20/2024 | Buy Now | 45.28% | UBS | Joshua Spector | $61 → $84 | Upgrade | Neutral → Buy | Get Alert |
03/19/2024 | Buy Now | 12.42% | Loop Capital | Christopher Kapsch | $55 → $65 | Maintains | Hold | Get Alert |
03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Peer Perform | Get Alert |
02/12/2024 | Buy Now | -4.88% | Loop Capital | Christopher Kapsch | $68 → $55 | Downgrade | Buy → Hold | Get Alert |
02/08/2024 | Buy Now | 2.04% | RBC Capital | Arun Viswanathan | $61 → $59 | Maintains | Outperform | Get Alert |
02/07/2024 | Buy Now | 5.5% | BMO Capital | Joel Jackson | $63 → $61 | Maintains | Market Perform | Get Alert |
02/07/2024 | Buy Now | -3.15% | Exane BNP Paribas | Laurent Favre | → $56 | Downgrade | Outperform → Neutral | Get Alert |
02/07/2024 | Buy Now | 31.44% | Keybanc | Aleksey Yefremov | $80 → $76 | Maintains | Overweight | Get Alert |
02/06/2024 | Buy Now | -4.88% | Mizuho | Christopher Parkinson | $59 → $55 | Maintains | Neutral | Get Alert |
01/16/2024 | Buy Now | -1.42% | B of A Securities | Steve Byrne | $60 → $57 | Downgrade | Neutral → Underperform | Get Alert |
01/11/2024 | Buy Now | 5.5% | UBS | Joshua Spector | $59 → $61 | Maintains | Neutral | Get Alert |
01/09/2024 | Buy Now | 38.36% | Keybanc | Aleksey Yefremov | $83 → $80 | Maintains | Overweight | Get Alert |
01/04/2024 | Buy Now | 27.98% | Roth MKM | Brian Wright | → $74 | Initiates | → Buy | Get Alert |
12/14/2023 | Buy Now | 8.96% | BMO Capital | Joel Jackson | $80 → $63 | Downgrade | Outperform → Market Perform | Get Alert |
12/07/2023 | Buy Now | — | Mizuho | Christopher Parkinson | — | Downgrade | Buy → Neutral | Get Alert |
11/17/2023 | Buy Now | 5.5% | RBC Capital | Arun Viswanathan | → $61 | Reiterates | Outperform → Outperform | Get Alert |
11/17/2023 | Buy Now | 2.04% | UBS | Joshua Spector | $64 → $59 | Maintains | Neutral | Get Alert |
11/02/2023 | Buy Now | 5.5% | RBC Capital | Arun Viswanathan | $80 → $61 | Maintains | Outperform | Get Alert |
11/01/2023 | Buy Now | -8.34% | JP Morgan | Jeffrey Zekauskas | $90 → $53 | Maintains | Neutral | Get Alert |
10/24/2023 | Buy Now | 38.36% | RBC Capital | Arun Viswanathan | $105 → $80 | Maintains | Outperform | Get Alert |
10/24/2023 | Buy Now | 38.36% | BMO Capital | Joel Jackson | $90 → $80 | Maintains | Outperform | Get Alert |
10/24/2023 | Buy Now | 7.23% | Fermium Research | Frank Mitsch | $85 → $62 | Maintains | Hold | Get Alert |
10/24/2023 | Buy Now | 21.07% | Morgan Stanley | Vincent Andrews | $100 → $70 | Downgrade | Overweight → Equal-Weight | Get Alert |
10/24/2023 | Buy Now | 43.55% | Keybanc | Aleksey Yefremov | $107 → $83 | Maintains | Overweight | Get Alert |
10/24/2023 | Buy Now | 2.04% | Goldman Sachs | Adam Samuelson | $135 → $59 | Downgrade | Buy → Neutral | Get Alert |
10/24/2023 | Buy Now | 8.96% | B of A Securities | Steve Byrne | → $63 | Downgrade | Buy → Neutral | Get Alert |
10/23/2023 | Buy Now | 26.25% | Wells Fargo | Richard Garchitorena | $99 → $73 | Maintains | Equal-Weight | Get Alert |
10/16/2023 | Buy Now | 62.57% | Vertical Research | Kevin McCarthy | → $94 | Upgrade | Hold → Buy | Get Alert |
10/10/2023 | Buy Now | 69.49% | Mizuho | Christopher Parkinson | $122 → $98 | Maintains | Buy | Get Alert |
10/03/2023 | Buy Now | 85.06% | Keybanc | Aleksey Yefremov | $117 → $107 | Maintains | Overweight | Get Alert |
09/25/2023 | Buy Now | 81.6% | RBC Capital | Arun Viswanathan | → $105 | Reiterates | Outperform → Outperform | Get Alert |
09/25/2023 | Buy Now | — | Redburn Atlantic | Tony Jones | → $71 | Downgrade | Buy → Neutral | Get Alert |
09/11/2023 | Buy Now | 72.95% | Morgan Stanley | Vincent Andrews | $110 → $100 | Maintains | Overweight | Get Alert |
09/05/2023 | Buy Now | 67.76% | UBS | Joshua Spector | $120 → $97 | Downgrade | Buy → Neutral | Get Alert |
08/21/2023 | Buy Now | 55.66% | JP Morgan | Jeffrey Zekauskas | → $90 | Initiates | → Neutral | Get Alert |
08/04/2023 | Buy Now | 111% | Mizuho | Christopher Parkinson | $127 → $122 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 102.35% | Keybanc | Aleksey Yefremov | $128 → $117 | Maintains | Overweight | Get Alert |
08/04/2023 | Buy Now | 74.68% | Credit Suisse | John Roberts | → $101 | Upgrade | Underperform → Neutral | Get Alert |
07/24/2023 | Buy Now | 76.41% | Wells Fargo | Richard Garchitorena | $142 → $102 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/12/2023 | Buy Now | 111% | B of A Securities | Steve Byrne | $139 → $122 | Maintains | Buy | Get Alert |
07/12/2023 | Buy Now | 90.25% | Morgan Stanley | Vincent Andrews | $145 → $110 | Maintains | Overweight | Get Alert |
07/11/2023 | Buy Now | 104.08% | Loop Capital | Christopher Kapsch | $148 → $118 | Maintains | Buy | Get Alert |
07/11/2023 | Buy Now | 90.25% | Morgan Stanley | Vincent Andrews | $145 → $110 | Maintains | Overweight | Get Alert |
07/11/2023 | Buy Now | 81.6% | RBC Capital | Arun Viswanathan | $136 → $105 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 74.68% | Credit Suisse | John Roberts | $120 → $101 | Maintains | Underperform | Get Alert |
07/11/2023 | Buy Now | 107.54% | BMO Capital | Joel Jackson | $145 → $120 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 119.65% | Mizuho | Christopher Parkinson | $147 → $127 | Maintains | Buy | Get Alert |
07/11/2023 | Buy Now | 121.38% | Keybanc | Aleksey Yefremov | $144 → $128 | Maintains | Overweight | Get Alert |
07/10/2023 | Buy Now | 81.6% | Fermium Research | Frank Mitsch | $125 → $105 | Maintains | Hold | Get Alert |
07/07/2023 | Buy Now | 150.78% | Morgan Stanley | Vincent Andrews | $145 → $145 | Reiterates | Overweight → Overweight | Get Alert |
05/04/2023 | Buy Now | 135.21% | RBC Capital | Arun Viswanathan | $140 → $136 | Maintains | Outperform | Get Alert |
05/03/2023 | Buy Now | 145.59% | Wells Fargo | Richard Garchitorena | $148 → $142 | Maintains | Overweight | Get Alert |
05/03/2023 | Buy Now | 154.24% | Mizuho | Christopher Parkinson | $150 → $147 | Maintains | Buy | Get Alert |
04/21/2023 | Buy Now | 159.43% | Mizuho | Christopher Parkinson | $147 → $150 | Maintains | Buy | Get Alert |
03/17/2023 | Buy Now | 168.07% | Redburn Partners | Tony Jones | → $155 | Upgrade | Neutral → Buy | Get Alert |
02/15/2023 | Buy Now | 174.99% | Goldman Sachs | Adam Samuelson | $155 → $159 | Maintains | Buy | Get Alert |
02/10/2023 | Buy Now | 142.13% | RBC Capital | Arun Viswanathan | $139 → $140 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | 150.78% | BMO Capital | Joel Jackson | $140 → $145 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | 149.05% | Keybanc | Aleksey Yefremov | $140 → $144 | Maintains | Overweight | Get Alert |
02/08/2023 | Buy Now | 107.54% | Credit Suisse | John Roberts | $112 → $120 | Maintains | Underperform | Get Alert |
02/08/2023 | Buy Now | 152.51% | Mizuho | Christopher Parkinson | → $146 | Maintains | Buy | Get Alert |
01/20/2023 | Buy Now | 155.97% | Citigroup | PJ Juvekar | $138 → $148 | Maintains | Buy | Get Alert |
01/12/2023 | Buy Now | 152.51% | Mizuho | Christopher Parkinson | $145 → $146 | Maintains | Buy | Get Alert |
01/12/2023 | Buy Now | 142.13% | Keybanc | Aleksey Yefremov | $139 → $140 | Maintains | Overweight | Get Alert |
01/11/2023 | Buy Now | 154.24% | UBS | Joshua Spector | $142 → $147 | Maintains | Buy | Get Alert |
01/10/2023 | Buy Now | 150.78% | Morgan Stanley | Vincent Andrews | $125 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
01/09/2023 | Buy Now | 155.97% | Wells Fargo | Michael Sison | $141 → $148 | Maintains | Overweight | Get Alert |
11/15/2022 | Buy Now | 157.7% | Loop Capital | Christopher Kapsch | $132 → $149 | Upgrade | Hold → Buy | Get Alert |
11/04/2022 | Buy Now | 133.48% | RBC Capital | Arun Viswanathan | $133 → $135 | Maintains | Outperform | Get Alert |
11/03/2022 | Buy Now | 140.4% | Keybanc | Aleksey Yefremov | $122 → $139 | Maintains | Overweight | Get Alert |
11/02/2022 | Buy Now | 93.7% | Credit Suisse | John Roberts | $105 → $112 | Maintains | Underperform | Get Alert |
08/04/2022 | Buy Now | 149.05% | Mizuho | Christopher Parkinson | $149 → $144 | Maintains | Buy | Get Alert |
08/03/2022 | Buy Now | 81.6% | Credit Suisse | John Roberts | $109 → $105 | Maintains | Underperform | Get Alert |
07/29/2022 | Buy Now | 157.7% | Mizuho | Christopher Parkinson | $155 → $149 | Maintains | Buy | Get Alert |
07/20/2022 | Buy Now | 111% | Keybanc | Aleksey Yefremov | → $122 | Upgrade | Sector Weight → Overweight | Get Alert |
07/13/2022 | Buy Now | 142.13% | UBS | Joshua Spector | $149 → $140 | Maintains | Buy | Get Alert |
06/21/2022 | Buy Now | 119.65% | B of A Securities | Steve Byrne | → $127 | Upgrade | Underperform → Buy | Get Alert |
06/13/2022 | Buy Now | — | Redburn Partners | Tony Jones | — | Downgrade | Buy → Neutral | Get Alert |
05/31/2022 | Buy Now | 88.52% | Credit Suisse | John Roberts | → $109 | Initiates | → Underperform | Get Alert |
05/04/2022 | Buy Now | 149.05% | Wells Fargo | Michael Sison | $150 → $144 | Maintains | Overweight | Get Alert |
04/29/2022 | Buy Now | 168.07% | Mizuho | Christopher Parkinson | $136 → $155 | Maintains | Buy | Get Alert |
04/14/2022 | Buy Now | 142.13% | Loop Capital | Christopher Kapsch | → $140 | Downgrade | Buy → Hold | Get Alert |
04/06/2022 | Buy Now | 159.43% | Wells Fargo | Michael Sison | $130 → $150 | Maintains | Overweight | Get Alert |
03/31/2022 | Buy Now | — | Monness, Crespi, Hardt | Chris Shaw | — | Downgrade | Buy → Neutral | Get Alert |
03/22/2022 | Buy Now | 121.38% | B of A Securities | Steve Byrne | → $128 | Downgrade | Buy → Underperform | Get Alert |
03/22/2022 | Buy Now | 162.88% | Citigroup | PJ Juvekar | $137 → $152 | Maintains | Buy | Get Alert |
02/11/2022 | Buy Now | 116.19% | Morgan Stanley | Vincent Andrews | $115 → $125 | Maintains | Equal-Weight | Get Alert |
02/10/2022 | Buy Now | 124.84% | Wells Fargo | Michael Sison | $123 → $130 | Maintains | Overweight | Get Alert |
02/10/2022 | Buy Now | 135.21% | Mizuho | Christopher Parkinson | $126 → $136 | Maintains | Buy | Get Alert |
01/31/2022 | Buy Now | — | Redburn Partners | Tony Jones | — | Initiates | → Buy | Get Alert |
01/11/2022 | Buy Now | 98.89% | Morgan Stanley | Vincent Andrews | $110 → $115 | Maintains | Equal-Weight | Get Alert |
01/04/2022 | Buy Now | 121.38% | UBS | John Roberts | $134 → $128 | Maintains | Buy | Get Alert |
The latest price target for FMC (NYSE:FMC) was reported by Wells Fargo on July 16, 2024. The analyst firm set a price target for $62.00 expecting FMC to rise to within 12 months (a possible 7.23% upside). 47 analyst firms have reported ratings in the last year.
The latest analyst rating for FMC (NYSE:FMC) was provided by Wells Fargo, and FMC maintained their equal-weight rating.
The last upgrade for FMC Corp happened on March 20, 2024 when UBS raised their price target to $84. UBS previously had a neutral for FMC Corp.
The last downgrade for FMC Corp happened on February 12, 2024 when Loop Capital changed their price target from $68 to $55 for FMC Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FMC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FMC was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest FMC (FMC) rating was a maintained with a price target of $68.00 to $62.00. The current price FMC (FMC) is trading at is $57.82, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.